Aspira Women's Health Inc. (AWHL)
| Market Cap | 11.96M -22.0% |
| Revenue (ttm) | 8.55M -8.0% |
| Net Income | -10.01M |
| EPS | -0.24 |
| Shares Out | 43.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,291 |
| Open | 0.3100 |
| Previous Close | 0.3200 |
| Day's Range | 0.2500 - 0.3100 |
| 52-Week Range | 0.2300 - 0.7100 |
| Beta | 2.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |
About Aspira Women's Health
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company’s products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; and OvaWatch, a assist in the initial and periodic clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OVAinform, a multi-marker test tha... [Read more]
Financial Performance
In 2025, Aspira Women's Health's revenue was $9.22 million, an increase of 0.37% compared to the previous year's $9.18 million. Losses were -$12.78 million, -2.40% less than in 2024.
Financial StatementsNews
Aspira Women's Health Quarterly report: Q2 2026
Aspira Women's Health has published its Q2 2026 quarterly earnings report on August 14, 2026.
Aspira Women's Health Proxy statement: Proxy filing
Aspira Women's Health filed a proxy statement on May 29, 2026, providing details for shareholder voting and corporate governance matters.
Aspira Women's Health Slides: Investor presentation
Aspira Women's Health has posted slides in relation to its latest quarterly earnings report, which was published on May 27, 2026.
Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26, ...
Aspira Women's Health Quarterly report: Q1 2026
Aspira Women's Health has published its Q1 2026 quarterly earnings report on May 15, 2026.
Aspira Women's Health Proxy statement: Proxy filing
Aspira Women's Health filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Aspira Women's Health Proxy statement: Proxy filing
Aspira Women's Health filed a proxy statement on April 24, 2026, providing details for shareholder voting and corporate governance matters.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)
AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease d...
Aspira Women's Health Annual report: Q4 2025
Aspira Women's Health has published its Q4 2025 annual report on April 1, 2026.
Aspira Women's Health Slides: Investor presentation
Aspira Women's Health has posted slides in relation to its latest quarterly earnings report, which was published on March 10, 2026.
Aspira Women's Health Registration statement: Registration Filing
Aspira Women's Health filed a registration statement on December 31, 2025, providing details about a securities offering with the SEC.
Aspira Women's Health Quarterly report: Q3 2025
Aspira Women's Health has published its Q3 2025 quarterly earnings report on November 14, 2025.
Aspira Women's Health Earnings release: Q3 2025
Aspira Women's Health released its Q3 2025 earnings on November 14, 2025, summarizing the period's financial results.
Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQX:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasi...
Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston
Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., abi...
Aspira Women's Health Registration statement: Registration Filing
Aspira Women's Health filed a registration statement on October 20, 2025, providing details about a securities offering with the SEC.
Aspira Women's Health Registration statement: Registration Filing
Aspira Women's Health filed a registration statement on September 30, 2025, providing details about a securities offering with the SEC.
Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise
$2.95 Million PIPE $112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's hea...
Aspira Women's Health Appoints New Chief Financial Officer
New Executive Brings 20+ Years of Accounting, Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQ...
Aspira Women's Health Earnings release: Q2 2025
Aspira Women's Health released its Q2 2025 earnings on August 13, 2025, summarizing the period's financial results.
Aspira Women's Health Quarterly report: Q2 2025
Aspira Women's Health has published its Q2 2025 quarterly earnings report on August 13, 2025.
Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive...
Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors
AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the...
Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients
Aspira and Dorsata Launch Clinical Workflow Tool for Adnexal Masses, Now Live for All Dorsata Clients, Adnexal Mass Evidence-Based Decision Support AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / Ju...
Aspira Women's Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women's Health
AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / June 11, 2025 / Aspira Women's Health Inc., ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering l...